Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy

Clinical trial NCT06433830 · UNKNOWN

Trial details

NCT number: NCT06433830
Sponsor: Sir Run Run Shaw Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Thrombocytopenia Radiotherapy Side Effect

Start date: 2022-05-10
Primary completion: 2025-05-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.